FDA Approves New Shingles Vaccine That Is More Than 90% Effective

BOSTON (CBS) – There’s a new shingles vaccine in town. Shingrix was approved by the FDA last week, and a CDC advisory panel just voted to recommend it for patients 50 and older.

It is given as two injections two to six months apart, and in studies the vaccine was found to be more than 90% effective.

Shingrix is not the only shingles vaccine available. Zostavax has been around for more than a decade, but it may not be as effective as this new vaccine, especially in older patients.

Vaccine experts are not only recommending the new vaccine for people who have never been vaccinated but say that people who got the old shingles vaccine should get this new one as well.

Shingles is a painful, itchy rash that can last for several weeks an in a small percentage of patients can lead to chronic pain. About a third of americans will develop shingles in their lifetime.

More from Dr. Mallika Marshall
Comments

One Comment

  1. you left out the most important information, is it live virus or not.

Leave a Reply

Please log in using one of these methods to post your comment:

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

More From CBS Boston

Opioid Crisis
Download Our App
Download Weather App

Watch & Listen LIVE